ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 530,70
0,07%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Singular Genomics Systems Inc (OMIC)

  7. Singular Genomics Systems Inc (OMIC) Actualités

OMIC

Singular Genomics Systems (OMIC)

Singular Genomics Systems Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OMIC
DateHeureSourceTitreSymboleSociété
01/06/202400h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
30/05/202422h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMICSingular Genomics Systems Inc
29/05/202422h05GlobeNewswire Inc.Singular Genomics to Present at the Goldman Sachs Global Healthcare ConferenceNASDAQ:OMICSingular Genomics Systems Inc
14/05/202422h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMICSingular Genomics Systems Inc
14/05/202422h05GlobeNewswire Inc.Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial ResultsNASDAQ:OMICSingular Genomics Systems Inc
01/05/202422h05GlobeNewswire Inc.Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:OMICSingular Genomics Systems Inc
18/03/202421h05GlobeNewswire Inc.Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:OMICSingular Genomics Systems Inc
04/03/202422h05GlobeNewswire Inc.Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024NASDAQ:OMICSingular Genomics Systems Inc
14/02/202422h16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OMICSingular Genomics Systems Inc
05/02/202416h55GlobeNewswire Inc.Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing PlatformNASDAQ:OMICSingular Genomics Systems Inc
05/02/202416h54GlobeNewswire Inc.Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic AnalysisNASDAQ:OMICSingular Genomics Systems Inc
07/01/202423h00GlobeNewswire Inc.Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 RevenueNASDAQ:OMICSingular Genomics Systems Inc
14/11/202322h01GlobeNewswire Inc.Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial ResultsNASDAQ:OMICSingular Genomics Systems Inc
09/11/202323h30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
24/10/202322h22GlobeNewswire Inc.Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023NASDAQ:OMICSingular Genomics Systems Inc
08/09/202314h00GlobeNewswire Inc.Singular Genomics to Present at the Gilmartin Group Emerging Growth Company ShowcaseNASDAQ:OMICSingular Genomics Systems Inc
09/08/202322h01GlobeNewswire Inc.Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial ResultsNASDAQ:OMICSingular Genomics Systems Inc
08/08/202322h05GlobeNewswire Inc.Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of DirectorsNASDAQ:OMICSingular Genomics Systems Inc
02/08/202322h05GlobeNewswire Inc.Singular Genomics Announces Participation in the UBS MedTech, Tools and Genomics SummitNASDAQ:OMICSingular Genomics Systems Inc
26/07/202322h05GlobeNewswire Inc.Singular Genomics to Report Second Quarter 2023 Financial Results on August 9, 2023NASDAQ:OMICSingular Genomics Systems Inc
20/06/202323h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OMICSingular Genomics Systems Inc
26/05/202312h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OMICSingular Genomics Systems Inc
09/05/202322h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OMICSingular Genomics Systems Inc
09/05/202322h01GlobeNewswire Inc.Singular Genomics Reports Recent Highlights and First Quarter 2023 Financial ResultsNASDAQ:OMICSingular Genomics Systems Inc
25/04/202322h05GlobeNewswire Inc.Singular Genomics to Report First Quarter 2023 Financial Results on May 9, 2023NASDAQ:OMICSingular Genomics Systems Inc
21/04/202300h39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OMICSingular Genomics Systems Inc
13/04/202322h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OMICSingular Genomics Systems Inc
02/03/202322h08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OMICSingular Genomics Systems Inc
02/03/202322h01GlobeNewswire Inc.Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:OMICSingular Genomics Systems Inc
23/02/202322h05GlobeNewswire Inc.Singular Genomics to Present at Cowen’s 43rd Annual Health Care ConferenceNASDAQ:OMICSingular Genomics Systems Inc
 Showing the most relevant articles for your search:NASDAQ:OMIC

Dernières Valeurs Consultées

ASE
NEORS
Neorion
COIN
BENUST
Ben
TG
4FF
China Railway Construction
NASDAQ
HYPR
Hyperfine
TG
TLIK
Teles
TG
PQIA
RadNet
NYSE
RNR-AL
LSE
GTX
TG
3PN
Pennon
TG
4KL
Ordinary share
LSE
HWDC
Hsbc Msci Wl Ch
LSE
JREZ
Jpm Ez Etf A
TSX
NGD
New Gold
LSE
SE77
Anz Bank 52
NASDAQI
FN25GI
First North 25 GI
TG
PV0
Piovan
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés